Frontiers | Treating Solid Organ Diseases with Innovative Chimeric-Antigen Receptor T-cells: Current indications, progress, limitations and potential strategies

Treating Solid Organ Diseases with Innovative Chimeric-Antigen Receptor T-cells: Current indications, progress, limitations and potential strategies

6,391
Total downloads
19k
Total views and downloads

Articles

EDITORIAL

Published on 24 Sep 2024

Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategies

Elizabeth Quackenbush
Jyothi Vijayaraghavan
Emrah Ilker Ozay
Rui-Ru Ji

doi 10.3389/fimmu.2024.1491982

332 views

SYSTEMATIC REVIEW

Published on 10 May 2024

The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review

Bibhu Prasad Satapathy
Pooja Sheoran
Rohit Yadav
Dewan Chettri
Dhruba Sonowal
Chinmayee Priyadarsini Dash
Prachi Dhaka
Vivek Uttam
Ritu Yadav
1 more
Aklank Jain

The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review

doi 10.3389/fimmu.2024.1389971

1,783 views
1 citation

ORIGINAL RESEARCH

Published on 18 Mar 2024

Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC

Lőrinc Nagy
Marianna Mezősi-Csaplár
István Rebenku
György Vereb
Árpád Szöőr

Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC

doi 10.3389/fimmu.2024.1365172

2,701 views
3 citations

ORIGINAL RESEARCH

Published on 14 Mar 2024

Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response

Yanping Yang
Yogindra Vedvyas
Yago Alcaina
Ju Y. Son
Irene M. Min
Moonsoo M. Jin

Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response

doi 10.3389/fimmu.2024.1355388

1,834 views
2 citations

MINI REVIEW

Published on 22 Feb 2024

Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic

Sergei Smirnov
Polina Mateikovich
Konstantin Samochernykh
Evgeny Shlyakhto

Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic

doi 10.3389/fimmu.2024.1335424

4,429 views
6 citations

REVIEW

Published on 31 Oct 2022

Chimeric antigen receptor T cells applied to solid tumors

Zhongguo Zhou
Can Tao
Jianting Li
Johnny Cheuk-on Tang
Albert Sun-chi Chan
Yuanyuan Zhou

Chimeric antigen receptor T cells applied to solid tumors

doi 10.3389/fimmu.2022.984864

4,944 views
13 citations

Share on

Frontiers in Immunology

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.5 impact factor
- 6.2 citescore

Impact

19kTopic views
12kArticle views
6,391Article downloads